Lanosterol biosynthesis pathway in GtoPdb v.2025.3

Authors

  • Helen E. Benson University of Edinburgh

DOI:

https://doi.org/10.2218/gtopdb/F104/2025.3

Abstract

Lanosterol is a precursor for cholesterol, which is synthesized primarily in the liver in a pathway often described as the mevalonate or HMG-CoA reductase pathway. The first two steps (formation of acetoacetyl CoA and the mitochondrial generation of (S)-3-hydroxy-3-methylglutaryl-CoA) are also associated with oxidation of fatty acids.

Downloads

Download data is not yet available.

Published

10-Sep-2025

Issue

Section

Articles

How to Cite

“Lanosterol biosynthesis pathway in GtoPdb v.2025.3” (2025) IUPHAR/BPS Guide to Pharmacology CITE, 2025(3). doi:10.2218/gtopdb/F104/2025.3.